Sort
30,917 grants matching “tumor microenvironment”
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$476,998Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Interstitial Fluid Flow Regulates Glioma Cell Invasion
$476,966Jennifer M Munson · Virginia Polytechnic Inst And St Univ · R37 · FY2021 · CA
Metastatic Clonal Heterogeneity and its Impact on Melanoma Therapeutic Resistance
$476,960Willy Hugo · University Of California Los Angeles · R01 · FY2020 · CA
GENETIC ALTERATION IN EPITHELIAL AND STROMAL COMPARTMENT OF BREAST ADENOCARCINOMA
$476,934Charis Eng · Ohio State University · P01 · FY2007 · CA
Definition of the Microenvironment in Breast Cancer
$476,933Mina J Bissell · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2019 · CA
Boosting Antitumor Immunity by Blocking Both Tumor and Adipose DDR1
$476,885Rong Li · George Washington University · R01 · FY2020 · CA
Engineered hybrid aging model for disease progression
$476,827Pinar Zorlutuna · University Of Notre Dame · R01 · FY2023 · CA
Integrin-mediated mechanisms of prostate cancer progression
$476,796Lucia R Languino · Thomas Jefferson University · R01 · FY2020 · CA
Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors
$476,752Wei R. Chen · University Of Oklahoma · R01 · FY2023 · CA
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
$476,736Xinna Zhang · Indiana University Indianapolis · R01 · FY2024 · CA
Regulation of metastatic progression by an endothelial-derived factor
$476,712Sohail F. Tavazoie · Rockefeller University · R01 · FY2021 · CA
Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas
$476,622Elias Sayour · University Of Florida · R37 · FY2022 · CA
IGF::OT::IGF ANTI FUSOBACTERIUM NUCLEATUM VACCINE FOR COLORECTAL CANCER IMMUNOPREVENTION
$476,619Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · N01 · FY2017 · CA
Nanoparticles-mediated combination therapy for breast cancer
$476,617Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Exploiting oxidative stress response in uveal melanoma liver metastases
$476,587Edward Hartsough · Drexel University · R01 · FY2024 · CA
A novel role of IGFBP7 in the microenvironment of hepatocellular carcinoma
$476,580Devanand Sarkar · Virginia Commonwealth University · R01 · FY2022 · CA
A novel role of IGFBP7 in the microenvironment of hepatocellular carcinoma
$476,580Devanand Sarkar · Virginia Commonwealth University · R01 · FY2023 · CA
Understanding the induction of T cell dysfunction in the context of lung cancer
$476,553Stefani Spranger · Massachusetts Institute Of Technology · R37 · FY2023 · CA
Image Biomarker Development for TreatmentEfficacy of Prostate Cancer to the Bone
$476,542Brian D. Ross · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
The role of Interleukin 17RB signaling in colorectal cancer progression
$476,341Sergei I Grivennikov · Cedars-Sinai Medical Center · R01 · FY2021 · CA
Mechanistic and therapeutic investigation of secondary metastatic seeding from breast cancer bone lesion
$476,224Xiang Zhang · Baylor College Of Medicine · R01 · FY2022 · CA
Mechanistic and therapeutic investigation of secondary metastatic seeding from breast cancer bone lesion
$476,224Xiang Zhang · Baylor College Of Medicine · R01 · FY2023 · CA
Mathematical Model-Guided Adoptive Immunotherapy in Bladder Cancer
$476,037Katarzyna Anna Rejniak · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
Role of EGFR in signaling by receptors of intracellular nucleic acids
$476,003Ganes C. Sen · Cleveland Clinic Lerner Com-Cwru · P01 · FY2016 · CA
Project 3: Phase-2 Trial of Oncolytic Poliovirus (PVSRIPO) combined with CCNU (lomustine) against Recurrent Glioblastoma
$475,986Darell D Bigner · Duke University · P01 · FY2019 · CA